HEALTH AND WELLNESS
incorporate preventative care to address the anticipated tsunami of patients from developing cirrhosis or life-threatening liver-related events."
With the ELF Test, your healthcare team has the tools to catch liver disease before it progresses and create a treatment plan that works for you. This may include lifestyle changes to prevent future damage to your liver. Speak with your doctor to know your liver health status today. Visit siemens-healthineers.us/elf for more information.
[1] Liver biopsy is currently the gold standard for diagnosing NASH and assessing fibrosis. In the U.S., the ELF Test is not for use in the diagnosis of NASH or for the staging of fibrosis. The ELF Test provides prognostic information supplemental to biopsy to assess the likelihood of progression to cirrhosis and liver-related clinical events.
The ELF Test is available at community laboratories and offers patients a minimally invasive tool for determining the risk of disease progression for earlier intervention.
Prepare a simple checklist of information to discuss with your doctor:
* List of medications - some may cause fat buildup in the liver
* Alcohol use
* Diet & exercise habits
* Known NAFLD risk factors
Non-Invasive Liver Disease Prognostic Tool
The ELF Test uses a routine blood sample and mathematical algorithm to generate a score that assesses the extent of liver damage. Clinicians can then utilize the score to understand the likelihood of progression to cirrhosis and other life-threatening liver-related clinical events. "The ELF Test provides clinicians and patients a valuable prognostic tool to help catch severe liver damage before it reaches that point," said Cooper. "We know that early intervention combined with lifestyle changes can positively impact patient outcomes, so this less invasive, easy-to-access test is a significant step in the right direction. Further, the ELF Test is strongly recommended in the 2022 American Association of Clinical Endocrinology (AACE) NAFLD Clinical Practice Guidelines. The guideline underscores the value of utilizing direct blood-based biomarkers in the NASH care continuum and also represents an opportunity to
"The ELF Test provides clinicians and patients a valuable prognostic tool to help catch severe liver damage before it reaches that point," ....